Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

SNX-5422 MeSH Supplementary Concept Data 2025


MeSH Supplementary
SNX-5422
Unique ID
C561943
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C561943
Entry Term(s)
PF 04929113
PF-04929113
PF-4929113
PF04929113
SNX-5422 mesylate
glycine trans-4-((2-(aminocarbonyl)-5-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl)phenyl)amino)cyclohexyl ester
Registry Numbers
BF52J69Q8T
0
K3BO8V06RM
Related Numbers
K3BO8V06RM
Heading Mapped to
*Benzamides
*Glycine
*Indazoles
Frequency
13
Note
prodrug of PF-04928473; orally bioavailable heat shock protein 90 inhibitor
Source
Cancer Res 2011 Sep 1;71(17):5838-49
Date of Entry
2011/10/23
Revision Date
2021/02/25
SNX-5422 Preferred
PF 04929113 Narrower
SNX-5422 mesylate Narrower
page delivered in 0.004s